DISTRIBUTION OF THE STARS IN THE GENERAL CATALOGUE OF VARIABLE STARSHOWELL SB.1982; PUBLICATIONS OF THE ASTRONOMICAL SOCIETY OF PACIFIC; ISSN 0004-6280; USA; DA. 1982; VOL. 94; NO 562; PP. 969-976; BIBL. 5 REF.Article

EFFECT OF SODIUM THIOSULFATE ON CIS-DICHLORODIAMMINEPLATINUM(II) TOXICITY AND ANTITUMOR ACTIVITY IN L1210 LEUKEMIAHOWELL SB; TAETLE R.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 4-5; PP. 611-616; BIBL. 17 REF.Article

ACHIEVEMENT OF LONG DURATION METHOTREXATE EXPOSURE WITH CONCURRENT LOW DOSE THYMIDINE PROTECTION: INFLUENCE ON METHATREXATE PHARMACOKINETICSHOWELL SB; TAMERIUS RK.1980; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1980; VOL. 16; NO 11; PP. 1427-1432; BIBL. 24 REF.Article

CHANGES IN GLOMERULAR FILTRATION RATE ASSOCIATED WITH HIGH-DOSE METHOTREXATE THERAPY IN ADULTS.HOWELL SB; CARMODY J.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 7; PP. 1388-1391; BIBL. 7 REF.Article

DIFFERENTIAL TOXICITY OF CARRIER-BOUND METHOTREXATE AGAINST TUMOR/BONE MARROW CELLS IN VIVOCHU BCF; HOWELL SB.1982; BIOCHEMICAL PHARMACOLOGY; ISSN 0006-2952; GBR; DA. 1982; VOL. 31; NO 21; PP. 3513-3517; BIBL. 10 REF.Article

PHARMACOLOGICAL AND THERAPEUTIC PROPERTIES OF CARRIER BOUND METHOTREXATE AGAINST TUMOR CONFINED TO A THIRD SPACE BODY COMPARTMENTCHU BCF; HOWELL SB.1981; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1981; VOL. 219; NO 2; PP. 389-393; BIBL. 20 REF.Article

SYNERGISTIC INTERACTION BETWEEN 1-BETA -D-ARABINOFURANOSYLCYTOSINE, THYMIDINE, AND HYDROXYUREA AGAINST HUMAN B CELLS AND LEUKEMIC BLASTS IN VITROSTREIFEL JA; HOWELL SB.1981; PROC. NATL. ACAD. SCI. U.S.A., BIOL. SCI.; ISSN 0273-1134; USA; DA. 1981; VOL. 78; NO 8; PP. 5132-5136; BIBL. 71 REF.Article

EFFECT OF PROBENECID ON CEREBROSPINAL FLUID METHOTREXATE KINETICSHOWELL SB; OLSHEN RA; RICE JA et al.1979; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1979; VOL. 26; NO 5; PP. 641-646; BIBL. 19 REF.Article

MODULATION OF CYTARABINE METABOLISM IN THE HUMAN PROMYELOCYTIC LEUKEMIA CELL LINE HL-60 POLYHYDROXY-SUBSTITUTED BENZOHYDROXAMIC ACIDSHOWELL SB; GILL S; ELFORD HL et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 10; PP. 1825-1829; BIBL. 40 REF.Article

DEFECTS IN CELL-MEDIATED IMMUNITY DURING GROWTH OF A SYNGENEIC SIMIAN VIRUS-INDUCED TUMOR = ALTERATIONS DE L'IMMUNITE A MEDIATION CELLULAIRE AU COURS DE LA CROISSANCE D'UNE TUMEUR SYNGENIQUE INDUITE PAR LE VIRUS SIMIENHOWELL SB; DEAN JH; LAW LW et al.1975; INTERNATION. J. CANCER; SWITZ.; DA. 1975; VOL. 15; NO 1; PP. 152-169; ABS. FR.; BIBL. 2P.Article

CELLULAR IMMUNITY IN MICE WITH SIMIAN VIRUS 40-INDUCED MKSA TUMORS: COMPARISON OF THREE ASSAYS OF TUMOR IMMUNITY = L'IMMUNITE CELLULAIRE CHEZ LES SOURIS AVEC DES TUMEURS MKSA INDUITES PAR LE SV 40. COMPARAISON DE 3 EPREUVES DE L'IMMUNITE ANTITUMORALEHOWELL SB; ESBER EC; LAW LW et al.1974; J. NATION. CANCER INST.; U.S.A.; DA. 1974; VOL. 52; NO 4; PP. 1361-1363; BIBL. 10 REF.Article

DETERMINATION OF PLASMA HYPOXANTHINE: A COMPARISON OF HIGH-PRESSURE LIQUID CHROMATOGRAPHIC AND OXYGEN CONSUMPTION METHODSSAUGSTAD OD; WUNG WE; HOWELL SB et al.1982; ANAL. BIOCHEM.; ISSN 0003-2697; USA; DA. 1982; VOL. 122; NO 1; PP. 159-163; BIBL. 20 REF.Article

SIGNIFICANCE OF VARIATION IN SERUM THYMIDINE CONCENTRATION FOR THE MARROW TOXICITY OF METHOTREXATEHOWELL SB; MANSFIELD SJ; TAETLE R et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 5; NO 4; PP. 221-226; BIBL. 32 REF.Article

THYMIDINE AND HYPOXANTHINE REQUIREMENTS OF NORMAL AND MALIGNANT HUMAN CELLS FOR PROTECTION AGAINST METHOTREXATE CYTOTOXICITYHOWELL SB; MANSFIELD SJ; TAETLE R et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 3; PP. 945-950; BIBL. 58 REF.Article

INTRAPERITONEAL CIS-DIAMMINEDICHLOROPLATINUM WITH SYSTEMIC THIOSULFATE PROTECTION = CIS-PLATINE INTRAPERITONEAL AVEC PROTECTION PAR LE THIOSULFATE PAR VOIE GENERALEHOWELL SB; PFEIFLE CE; WUNG WE et al.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 3; PP. 1426-1431; ABS. ENG; BIBL. 36 REF.; GRAPHArticle

COMPARISON OF THE ACTIVITY OF DOXORUBICIN ANALOGUES USING COLONY-FORMING ASSAYS AND HUMAN XENOGRAFTSTAETLE R; HOWELL SB; GIULIANI FC et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 8; PP. 1455-1461; BIBL. 22 REF.Article

HEMODIALYSIS AND ENZYMATIC CLEAVAGE OF METHOTREXATE IN MAN.HOWELL SB; BLAIR HE; UREN J et al.1978; EUROP. J. CANCER; G.B.; DA. 1978; VOL. 14; NO 7; PP. 787-792; BIBL. 23 REF.Article

CELL INTERACTIONS IN ADOPTIVE IMMUNE REJECTION OF A SYNGENEIC TUMORHOWELL SB; DEAN JH; ESBER EC et al.1974; INTERNATION. J. CANCER; SWITZ.; DA. 1974; VOL. 14; NO 5; PP. 662-674; ABS. FR.; BIBL. 1 P. 1/2Article

HIGH-DOSE ALLOPURINOL MODULATION OF 5-FU TOXICITY: PHASE I TRIAL OF AN OUTPATIENT DOSE SCHEDULECAMPBELL TN; HOWELL SB; PFEIFLE C et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 9; PP. 1723-1727; BIBL. 25 REF.Article

LONG-DURATION INTRACAVITARY INFUSION OF METHOTREXATE WITH SYSTEMIC LEUCOVORIN PROTECTION IN PATIENTS WITH MALIGNANT EFFUSIONSHOWELL SB; CHU BBF; WUNG WE et al.1981; J. CLIN. INVEST.; ISSN 0021-9738; USA; DA. 1981; VOL. 67; NO 4; PP. 1161-1170; BIBL. 45 REF.Article

METHOTREXATE PHARMACOKINETICS AFTER INTRAARTICULAR INJECTION IN PATIENTS WITH RHEUMATOID ARTHRITISWIGGINGTON SM; CHU BCF; WEISMAN MH et al.1980; ARTHRIT. AND RHEUMATISM; USA; DA. 1980; VOL. 23; NO 1; PP. 119-122; BIBL. 15 REF.Article

THYMIDINE REQUIREMENTS FOR THE RESCUE OF PATIENTS TREATED WITH HIGH-DOSE METHOTREXATEHOWELL SB; HERBST K; BOSS GB et al.1980; CANCER RES.; USA; DA. 1980; VOL. 40; NO 6; PP. 1824-1829; BIBL. 39 REF.Article

ANTITUMOR ACTIVITY OF L-CANAVANINE AGAINST L1210 MURINE LEUKEMIAGREEN MH; BROOKS TL; MENDELSOHN J et al.1980; CANCER RES.; USA; DA. 1980; VOL. 40; NO 3; PP. 535-537; BIBL. 11 REF.Article